Xiaoping Ma

机构：Shihezi University, Xinjiang Medical University, Yanbian University, Beijing Jiaotong University, Lanzhou Jiaotong University, Tumor Hospital of Xinjiang Medical University, Zhongshan Hospital, First Affiliated Hospital of Shihezi University Medical College, Liaocheng People's Hospital · ORCID：0000-0003-3202-2514

发表论文 82 篇 · 总被引 1179 次 · h-index 20

代表论文

• Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study (2024 · Frontiers in Endocrinology · 被引 48)
• POLR2A Promotes the Proliferation of Gastric Cancer Cells by Advancing the Overall Cell Cycle Progression (2021 · Frontiers in Genetics · 被引 23)
• Significance of HOXD transcription factors family in progression, migration and angiogenesis of cancer (2022 · Critical Reviews in Oncology/Hematology · 被引 20)
• Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases (2022 · Annals of Medicine · 被引 14)
• MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway (2022 · Cancer Cell International · 被引 14)
• Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors (2021 · European Journal of Medicinal Chemistry · 被引 14)